March 27, 2022
1 min watch
Lloyd S. Miller, MD, PhD
Miller reports being an employee of Janssen Research & Development and owning Johnson & Johnson stocks.
BOSTON — In this video, Lloyd S. Miller, MD, PhD, of Janssen Research & Development, summarizes Tremfya (guselkumab) data in psoriasis and psoriatic arthritis treatment presented at the American Academy of Dermatology Annual Meeting.